This is the authors' abstract. We don't add key points for this paper.
Extract Hypoglossal nerve stimulation (HNS) has emerged as a promising alternative therapy to positive airway pressure for selected patients with obstructive sleep apnoea (OSA). Nevertheless, robust predictors of treatment response remain elusive, despite over a decade of research [1, 2]. Current eligibility criteria for HNS are largely based on general clinical metrics, such as body mass index and baseline apnoea–hypopnoea index (AHI), derived from early clinical trials [3, 4]. While useful for initial screening, these parameters lack anatomical specificity and do not fully capture the underlying mechanisms driving airway collapse. As a result, a substantial proportion of eligible patients still fail to respond to HNS [3, 5].
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: